Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Martina Oberländer"'
Autor:
Christoph Dumke, Timo Gemoll, Martina Oberländer, Sandra Freitag-Wolf, Christoph Thorns, Axel Glaessgen, Rinse Klooster, Silvère M. van der Maarel, Jerker Widengren, Christian Doehn, Gert Auer, Jens K. Habermann
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Current prostate cancer risk classifications rely on clinicopathological parameters resulting in uncertainties for prognostication. To improve individual risk stratification, we examined the predictive value of selected proteins with respect
Externí odkaz:
https://doaj.org/article/68a3591cd68b4f21a9b0964e6eb15294
Autor:
Jens K. Habermann, Lars Hanker, Achim Rody, Julika Ribbat‑Idel, Annika Waldmann, Constanze Banz‑Jansen, Frank Köster, Marc Thill, Friederike Hoellen, Uwe Holtrich, Mareike Hörmann, Martina Oberländer, Thomas Karn, Ahmed El‑Balat
Publikováno v:
Molecular and Clinical Oncology. 7:880-884
Claudin-1 is a tight junction protein that has been demonstrated to be involved in tumorigenesis and tumor progression in various types of solid tumors. In the present study, the protein expression of claudin-1 in squamous cervical cancer tissues obt
Autor:
Kathrin Kalies, Katharina Schillo, Sonja Hartwig, Christoph Thorns, Karl F. Karstens, Jens K. Habermann, Martina Oberländer, Stefan Lehr, Sarah Strohkamp, Gia G. Hò, Timo Gemoll, Sophie L. Kollbeck
Publikováno v:
Oncotarget
// Timo Gemoll 1, * , Sophie L. Kollbeck 1, * , Karl F. Karstens 1 , Gia G. Ho 1 , Sonja Hartwig 2, 3 , Sarah Strohkamp 1 , Katharina Schillo 1 , Christoph Thorns 4 , Martina Oberlander 1 , Kathrin Kalies 5 , Stefan Lehr 2, 3 and Jens K. Habermann 1
Autor:
Julika Ribbat-Idel, Constanze Banz-Jansen, Christoph Thorns, Jens K. Habermann, Martina Oberländer, Maria Heide, M.P. Gebhard, Friederike Hoellen, Achim Rody, Frank Köster, Annika Waldmann, Marc Thill
Publikováno v:
Oncology Letters
Cyclooxygenase-2 (COX-2) is associated with carcinogenesis and tumor progression. The current study analyzed the effect of COX-2 expression in patients with invasive squamous cervical cancer. Tissue samples from 123 cervical cancer patients were coll
Autor:
Regina Kaatz, Alexandra König, Hans-Ulrich Prokosch, Ernst Klar, Valentina Bogoevska, Uwe J. Roblick, Michael Hackmann, Ria Uhlig, Michael Linnebacher, Jakob R. Izbicki, Christiane Brodersen, Hans-Peter Bruch, Jan Christoph, Jürgen Büning, Jens K. Habermann, Sebastian Mate, Christoph Thorns, Josef Ingenerf, Friedrich Prall, Martina Oberländer, Emre F. Yekebas, Mathias Krohn, Brigitte Vollmar
Publikováno v:
Langenbeck's Archives of Surgery. 398:251-258
Research projects and clinical trials strongly rely on high-quality biospecimens which are provided by biobanks. Since differences in sample processing and storage can strongly affect the outcome of such studies, standardization between biobanks is n
Autor:
Verena Bente, Helena Voulgaris, Markus Kleemann, Uwe J. Roblick, Hans-Peter Bruch, Tilman Laubert, Martina Oberländer, Sandra Freitag-Wolf, Jens K. Habermann, C. Bürk, Katharina Schillo
Publikováno v:
International Journal of Colorectal Disease. 28:767-775
Presently, no markers exist to predict metachronous metastasis at the time a primary colorectal cancer is diagnosed. While aneuploidy indicates poor survival prognosis and elevated carcinoembryonic antigen (CEA) levels the presence of recurrent disea
Autor:
Martin Berghoff, Martina Oberländer
Publikováno v:
Molecular and Cellular Neuroscience. 45:59-65
In myelin protein zero (P0)-deficient mice immune cells are critically involved in the pathogenesis of a primary genetic disease. Previously it has been shown that the chemokine CCL2 affects the functional properties of endoneurial macrophages in het
Autor:
Antje Sucker, Peter Bronsert, Bastian Malzkorn, Angelika Duda, Martin Werner, Martina Oberländer, Hans-Peter Bruch, Guido Reifenberger, Dirk Schadendorf, Michael Linnebacher, Elmar Stickeler, Jens K. Habermann, Parviz Ahmad-Nejad, Michael Neumaier
Biobanks are becoming increasingly important for assessment of disease risk as well as identification and validation of new diagnostic biomarkers and druggable targets. The validity of data obtained from biobanks is critically limited by the biomater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e0c22c6f0f0f4133dca0093273870bc
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=84946838768
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=84946838768
Autor:
F. Ernst, C. Thorns, Jens K. Habermann, Martina Oberländer, T. Braunschweig, H. Alkemade, Stefanie Bünger
Publikováno v:
Pathology oncology research : POR. 20(3)
A major focus in cancer research is the identification of biomarkers for early diagnosis, therapy prediction and prognosis. Hereby, validation of target proteins on clinical samples is of high importance. Tissue microarrays (TMAs) represent an essent
Autor:
Mats Borén, Stefan Lehr, Oliver Löwe, Uwe J. Roblick, Jens K. Habermann, Sonja Hartwig, Martina Oberländer, Timo Gemoll, Gert Auer, Hans Jörnvall
Publikováno v:
Archives of physiology and biochemistry. 119(3)
Biological material reflecting the in vivo composition of markers provides a high potential for biomarker discovery.We compared the serum proteome following heat- and nitrogen-preservation, with and without subsequent storage at room temperature.Seru